4 Recruiting Clear Cell Renal Cell Carcinoma Phase 3 Clinical Trials
Active phase 3 studies for clear cell renal cell carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Clear Cell Renal Cell Carcinoma studiesPhase 3 Studies for Clear Cell Renal Cell Carcinoma
🔵 Active, Not Recruiting Phase3
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
📍 Local Institution — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
📍 Cancer Center at Saint Joseph's — Phoenix, Arizona
View Study & Checklist ➔